<DOC>
	<DOCNO>NCT01461993</DOCNO>
	<brief_summary>This clinical study ass safety , tolerance immunogenic response Gardasil ( human papilloma virus ( HPV ) ) rLP2086 vaccine . Healthy male female subject randomize 1 3 group ; trial observer-blinded study injection give ; , vaccinate either Gardasil rLP2086 concomitantly , rLP2086 saline concomitantly , Gardasil saline concomitantly . The subject adolescent child age 11 17 year old .</brief_summary>
	<brief_title>A Clinical Trial Study Safety , Tolerance Immunogenic Response Gardasil Bivalent rLP2086 Vaccine When Given Same Time Children Between Ages 11 17</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female subject 11 17 year old time start study . Subject must healthy determine obtain subject 's medical history , receive physical examination judgment investigator . Previous vaccination meningococcal serogroup B vaccine . Previous vaccination HPV vaccine . Contraindication vaccination Gardasil HPV vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>vaccine</keyword>
	<keyword>rLP2086</keyword>
	<keyword>Gardasil</keyword>
	<keyword>HPV</keyword>
	<keyword>meningitis B</keyword>
	<keyword>N. meningitidis serogroup B</keyword>
	<keyword>adolescent</keyword>
	<keyword>single-blind</keyword>
	<keyword>Meningococcal Vaccines</keyword>
</DOC>